American Portfolios Advisors - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 46 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2022$4,270
-8.2%
1,0000.0%0.00%
Q4 2021$4,650
-22.3%
1,000
-33.3%
0.00%
Q3 2021$5,985
-6.8%
1,5000.0%0.00%
Q2 2021$6,420
+0.9%
1,5000.0%0.00%
Q1 2021$6,360
+9.3%
1,5000.0%0.00%
Q4 2020$5,820
-50.2%
1,500
-48.3%
0.00%
-100.0%
Q3 2020$11,687
-33.1%
2,900
-29.3%
0.00%0.0%
Q2 2020$17,4664,1000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders